| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.0M | +27.1% |
| SG&A Expense | $8.5M | +16.3% |
| Net Income | -$14.6M | -20.5% |
| EPS (Basic) | -$1.15 | -2.7% |
| EPS (Diluted) | -$1.15 | -2.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $129K | — |
| Total Assets | $7.7M | -17.8% |
| Current Liabilities | $3.0M | +47.6% |
| Total Liabilities | $3.0M | +47.6% |
| Stockholders' Equity | $4.7M | -36.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.8M | -29.9% |
| Financing Cash Flow | $8.2M | +120.9% |